Form 4: Hims & Hers CFO Exercises Options, Sells Shares

Hims & Hers Health, Inc.'s CFO, Oluyemi Okupe, exercised stock options and sold 11,581 shares of Class A Common Stock for an average price of $43.6895 per share.

Summary

• Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), executed transactions on August 26, 2025.
• Exercised stock options to acquire 11,581 shares of Class A Common Stock at an exercise price of $5.01 per share.
• Subsequently sold all 11,581 shares of Class A Common Stock at an average weighted price of $43.6895 per share, with individual sales ranging from $43.55 to $43.86.
• These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024.
• Following these transactions, direct beneficial ownership of Class A Common Stock stands at 116,806 shares, with an additional 7,853 shares held indirectly through the Oluyemi Okupe Separate Property Trust dtd 9-1-2021.
• The CFO retains 349,784 stock options after the reported exercise.

Sentiment

Score: 7

Explanation: The transaction reflects a profitable exercise of options by a key executive, indicating significant stock price appreciation from the option grant price. While a sale follows, it is executed under a pre-planned Rule 10b5-1, which generally mitigates negative interpretations of insider selling.

Positives

• The CFO's exercise of stock options indicates a significant appreciation in the company's stock price from the option grant price of $5.01 to the sale price of $43.6895.
• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which suggests a systematic approach to managing equity holdings rather than a reaction to immediate market conditions.

Negatives

• The sale of 11,581 shares by a key executive, even if pre-planned, reduces the CFO's direct equity exposure to the company.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The profitable exercise and sale of options by the CFO under a 10b5-1 plan may be viewed as a positive indicator of past stock performance, but also represents a reduction in direct insider holdings.

Key Dates

Recommendation

This filing details a routine insider transaction under a pre-established 10b5-1 plan, where the CFO exercised options and sold shares for a significant profit. This indicates past stock appreciation but does not provide new fundamental information about the company's future performance or strategic direction. While the sale reduces direct insider ownership, the pre-planned nature mitigates immediate negative sentiment. Investors should hold and await further operational updates or financial results to reassess the company's trajectory.

Keywords

Hims & Hers Health, HIMS, SEC Form 4, Insider Trading, Stock Options, CFO, Equity Sale, Rule 10b5-1